Session » Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies
-
Abstract Number: 1588
Risk of Cancer in Patients with Psoriasis/Psoriatic Arthritis: A Population-Based Study in the Province of British Columbia
-
Abstract Number: 1589
Cardiac Biomarkers and Carotid Atherosclerosis and Its Progression in Psoriatic Disease
-
Abstract Number: 1590
Metabolomics Profile Predicts Carotid Atherosclerosis Progression in Psoriatic Disease
-
Abstract Number: 1591
Is Enthesitis a Marker of Disease Severity in Early Psoriatic Arthritis?
-
Abstract Number: 1592
Frequency and Pattern of the Uveitis in Spondyloarthritis with Biological Therapy
-
Abstract Number: 1593
Extra-Articular Manifestations, Neoplasms and Cardiovascular Events in a Series of Spondyloarthritis from a Single Center
-
Abstract Number: 1594
Liver Enzyme Elevation in Patients with Ankylosing Spondylitis Treated with TNF Inhibitor: A Single-Center Historical Cohort Study
-
Abstract Number: 1595
Malignancy in Psoriatic Disease
-
Abstract Number: 1596
Atherosclerotic Cardiovascular Disease in Psoriatic Arthritis: Evaluation of Risk Factor Management and Use of Aspirin and Statin for Prevention in a Primary Care Setting
-
Abstract Number: 1597
Bone Mineral Density and Serum Biomarkers of Bone Turnover in Ankylosing Spondylitis Patients Treated with Secukinumab: 2-Year Data from the Pivotal Phase 3 Study
-
Abstract Number: 1598
Depression and Anxiety Reduce Probability of Achieving a State of Minimal Disease Activity in Patients with Psoriatic Arthritis
-
Abstract Number: 1599
Performance of Referral Strategies for Spondyloarthritis: A Population-Based Nationwide Study
-
Abstract Number: 1600
Psychometric Properties of the Assessment of Spa International Society Health Index in Patients with Active As/Radiographic Axial Spa in a Phase 3 Clinical Study
-
Abstract Number: 1601
Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis: Results from a Cross-Sectional Observational Study in the United States
-
Abstract Number: 1602
Disease Characteristics, Quality of Life, and Work Productivity By Enthesitis Sites: Real-World Data from the US Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
-
Abstract Number: 1603
Gender-Specific Differences in Chinese Patients with Ankylosing Spondylitis
-
Abstract Number: 1604
Impact of Time to Minimal Disease Activity and Quality of Life One Year after Diagnosis of Psoriatic Arthritis
-
Abstract Number: 1605
Prevalence of Anterior Uveitis in Patients with Spondyloarthropathy in a Single US Academic Center: A Retrospective Study from Routine Care
-
Abstract Number: 1606
The 66/68 Joint Count for the Measurement of MSK Disease Activity/Peripheral Joint Activity in Psa: A Grappa-Omeract Working Group Initiative
-
Abstract Number: 1607
Achievement of Cdapsa Low Disease Activity or Remission Is Associated with Control of Articular and Extra-Articular Manifestations of Active Psa in Subjects Treated with Apremilast
-
Abstract Number: 1608
The Value of Carotid Ultrasound in Cardiovascular Risk Stratification in Patients with Psoriatic Disease
-
Abstract Number: 1609
The Incidence Rate of Spondyloarthritis in Slovenia
-
Abstract Number: 1610
Incremental Benefits to Quality of Life Associated with Achieving Higher Levels of American College of Rheumatology Response and Skin Clearance in Patients with Psoriatic Arthritis
-
Abstract Number: 1611
Hospitalizations for Serious Infections in Psoriatic Arthritis Patients: Data from the National Inpatient Sample 2000-2014
-
Abstract Number: 1612
Myocardial Infarctions Among Ankylosing Spondylitis Patients in a Large US Insurance Database
-
Abstract Number: 1613
Dactylitis in Early Spondyloarthritis. Baseline Data from a Prospective French National Cohort
-
Abstract Number: 1614
Prevalence of Sonographic Enthesitis in Patients with Psoriasis without Arthritis and Its Association Risk Factors of Psoriatic Arthritis
-
Abstract Number: 1615
Comparative Risk of Atrial Fibrillation and Cardiovascular Events between TNF-Inhibitors and Ustekinumab in Patients with Psoriasis and Psoriatic Arthritis: A Population-Based Multi-Database Study
-
Abstract Number: 1616
Region-Specific Differences in Clinical Presentation of Patients with Axial Spondyloarthritis – Results from a Large Multinational Cohort Study
-
Abstract Number: 1617
Influence of Disease Activity in the Physical Activity of Psoriatic Arthritis Patients
-
Abstract Number: 1618
Adipose Tissue Inflammation in Psoriatic Arthritis: Overexpression of a Wide Array of Inflammatory Mediators and Associations with Disease and Treatment Characteristics
-
Abstract Number: 1619
Patterns and Outcomes on As Patients Disease Activity Using Smart System of Disease Management (SSDM): Analysis of T2T Pattern Shift and the Correlation between Disease Activity and Mental Health
-
Abstract Number: 1620
Lateral DXA More Effective in Detecting Osteoporosis Than Conventional DXA in Axial Spondyloarthropathy
-
Abstract Number: 1621
Higher Serum Uric Acid Levels Protect Against Osteoporosis in Patients with Axial Spondyloarthropathy
-
Abstract Number: 1622
ASAS Consensus on Spanish Nomenclature for Spondyloarthritis
-
Abstract Number: 1623
Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey
-
Abstract Number: 1624
Real-World Insight into the Disease Burden and Treatment of Spondyloarthritis from a US-Based Life Impact Survey
-
Abstract Number: 1625
Association of HLA-B Type and Sacroiliitis in Patients with Psoriatic Arthritis
-
Abstract Number: 1626
The Disease Expression in Familial and Sporadic Axial Spondyloarthritis Patients
-
Abstract Number: 1627
Assessment of Myocardial Dysfunction Using Speckle Tracking Echocardiography in Patients with Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
-
Abstract Number: 1628
Is Axial Psoriatic Arthritis Distinct from Ankylosing Spondylitis with and without Concomitant Psoriasis?
-
Abstract Number: 1629
Hyperlipoproteinemia (a) in Patients with Spondyloarthritis. Results of the CARMA Study
-
Abstract Number: 1630
Do Symptoms of Depression and Anxiety Influence Treatment Response and Long-Term Physical Health Outcomes in Ankylosing Spondylitis?
-
Abstract Number: 1631
Incidence of Uveitis in Patients with Spondyloarthritis: The Impact of Biologics Era.a Multicenter Study Using Data from International ASAS-Comospa Study
-
Abstract Number: 1632
Ultrasonographic Evaluation of the Enthesis in Patients Affected By Entheropatic Spondiloarthritis. Focus on Distal Enthesis of the Patellar Tendon
-
Abstract Number: 1633
Fragility Fractures in Psoriatic Arthritis Patients: A Matched-Control Study
-
Abstract Number: 1634
The Impact of Comorbidities on Physical Function in Patients with Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics. Results of a National Study
-
Abstract Number: 1635
Validity of Patient-Reported Outcomes Measurement Information System Measures in Ankylosing Spondylitis Patients
-
Abstract Number: 1637
Serious Infections Among Psoriatic Arthritis Patients Taking TNF Inhibitors Versus Non-TNF Biologics: A Systematic Review and Network Meta-Analysis
-
Abstract Number: 1638
Impact of Extra-Articular Manifestations on Patient-Reported Outcomes in Ankylosing Spondylitis and Psoriatic Arthritis: Interim Results from the Complete Studies
-
Abstract Number: 1639
Uveitis As First Symptom in Patients with Spondyloarthritis. Data from the Spanish Registry Regisponser
-
Abstract Number: 1640
Work Disability in Psoriatic Arthritis Patients
-
Abstract Number: 1641
Spa-Net: A Disease-Specific Integrated Ehealth System and Quality Registry for Spondyloarthritis in Daily Practice in the Netherlands
-
Abstract Number: 1643
Psa Impact of Disease Questionnaire Scores Are Correlated with Disease Activity, As Measured By Cdapsa in Patients with Psa
-
Abstract Number: 1644
Improvement in Morning Stiffness in Subjects with Psa Is Associated with Improvements in Pain, Physical Function, and Patient Global Response to Treatment
-
Abstract Number: 1645
Clinical Features of Axial Spondyloarthritis Patients Diagnosed in Secondary Versus a Tertiary Hospital
-
Abstract Number: 1646
Prevalence of Spondyloarthritis in Patients with Anterior Uveitis
-
Abstract Number: 1647
Uveitis, the Most Faithful Partner of Axial Spondyloarthritis
-
Abstract Number: 1648
Smoking Status in Patients with Psoriasis and Psoriatic Arthritis: An Irish Perspective
-
Abstract Number: 1649
Cohort Identification of Axial Spondyloarthritis in a Large Healthcare Dataset: Current and Future Methods
-
Abstract Number: 1650
Subclinical Atheromatosis and Estimation of Cardiovascular Risk in Patients with Axial Spondyloarthritis
-
Abstract Number: 1651
Epidemiology of Depression and Anxiety in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis
-
Abstract Number: 1652
Musculoskeletal Involvement in Inflammatory Bowel Disease’S Patients: A Mono Centric Experience
-
Abstract Number: 1653
Psychological Distress in Patients with Axial Spondyloarthritis in Europe. Results from the European Map of Axial Spondyloarthritis Survey
-
Abstract Number: 1654
Improvement of Cytological Grade and Tear Production in Ankylosing Spondylitis Patients Under Anti-TNF Therapy: A Long-Term Follow-up
-
Abstract Number: 1655
Achieving Remission in Psoriatic Arthritis By Early Initiation of TNF Inhibition: A Double-Blind, Randomized, Placebo-Controlled Trial of Golimumab + Methotrexate Versus Placebo + Methotrexate
-
Abstract Number: 1656
Is a Positive Family History of Spondyloarthritis Relevant for Diagnosing Axial Spondyloarthritis Once HLA-B27 Status Is Known? Data from the ASAS, DESIR, and SPACE Cohorts
-
Abstract Number: 1657
The Effect of Guselkumab on Enthesitis: Results from a Phase 2 Study in Patients with Active Psoriatic Arthritis
-
Abstract Number: 1658
Which Factors Influence the Diagnostic Delay in Patients with Axial Spondyloarthritis?
-
Abstract Number: 1659
Sustained Improvements in Physical Function, Quality of Life, and Work Productivity after Ixekizumab Therapy in Patients with Active Psoriatic Arthritis: 3-Year Results
-
Abstract Number: 1660
Depression Has a Greater Impact on Psoriatic Arthritis Than Rheumatoid Arthritis
-
Abstract Number: 1661
Factors That May be Associated with Uveitis in Patients with Spondyloarthritis